B cell depletion therapy exacerbates murine primary biliary cirrhosis - Wikidata - wikimedia - TriplyDB

B cell depletion therapy exacerbates murine primary biliary cirrhosis

B cell depletion therapy exacerbates murine primary biliary cirrhosis

http://www.wikidata.org/entity/Q34678839

about

Xenobiotics and loss of tolerance in primary biliary cholangitis Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis Liver immunology.Pathological features of new animal models for primary biliary cirrhosis.Environmental Basis of Autoimmunity.Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis.αβ TCR⁺ T cells, but not B cells, promote autoimmune keratitis in b10 mice lacking γδ T cells Transient depletion of B cells in young mice results in activation of regulatory T cells that inhibit development of autoimmune disease in adults Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance.Advances in pharmacotherapy for primary biliary cirrhosis.B cell depletion in treating primary biliary cirrhosis: pros and cons IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection Genome-Wide Association Studies in Primary Biliary Cirrhosis.Role of autoimmunity in primary biliary cirrhosis.The immunopathology of liver granulomas in primary biliary cirrhosis.A case of primary biliary cirrhosis that progressed rapidly after treatment involving rituximab.Dysregulation of peritoneal cavity B1a cells and murine primary biliary cholangitis.Immunological orchestration of liver fibrosis.Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.Novel therapeutic targets in primary biliary cirrhosis.Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.It is time to change primary biliary cirrhosis (PBC): New nomenclature from "cirrhosis" to "cholangitis", and upcoming treatment based on unveiling pathology.Recruitment mechanisms of primary and malignant B cells to the human liver.Animal models of primary biliary cirrhosis.B cells expressing CD11b effectively inhibit CD4+ T-cell responses and ameliorate experimental autoimmune hepatitis in mice.Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.Hepatic B cells are readily activated by Toll-like receptor-4 ligation and secrete less interleukin-10 than lymphoid tissue B cells.From pathogenesis to novel therapies in the treatment of primary biliary cholangitis.B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid.The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis.Altered Distribution of Peripheral Blood Maturation-Associated B-Cell Subsets in Chronic Alcoholism.Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types.Primary biliary cholangitis: new treatments for an old disease.

P2860

Q26772312-AAA13BE3-58EC-4393-BBFB-270ACE769997 Q28533202-4F5A78CA-42CF-48E5-B8EA-357C283C7A21 Q34359990-99CD5AE3-5D26-461B-8ED7-142F895EDFB3 Q35203353-AD615710-0542-4633-A5F8-999A277A0EEE Q35638839-9C556174-5BFF-4495-A244-DFEA8D024A0C Q35736729-FADB15B2-427A-4AAD-A8D4-D86209C3C83C Q35797232-66BCF166-1AB4-4B84-BDA9-B7E7C19120DD Q35852020-8AF81F73-38B6-4BA3-B6EF-DFBC9742B465 Q36001633-9358578D-5CF7-4BDD-BE0A-3B03C3329D8A Q36116022-500383C4-2907-4A70-8407-1F331563C0E3 Q36166941-6E36BC92-87B1-4DEF-9C23-7CF3E041BC04 Q36345904-3668D424-9CE0-4827-BD08-CAFDA50D310F Q36383011-DBF56E91-F986-4671-9D99-91E20BD0F162 Q36529131-430B4AD6-2766-445C-B2E3-AB70D7C3F101 Q36573783-0D2C1F8A-F02E-4A51-9638-456CDD693DB9 Q36851472-C6B3F50E-B7EA-4673-AF91-AA142C844F2A Q37317145-2E1EFA3D-E65A-4613-B5BF-EB08390D76D0 Q38018539-6F64CB47-5D3B-4C65-80A2-49C1F9A2D6A7 Q38244716-657358FE-063C-4B18-97FE-4C5D0D0309B2 Q38342107-3D20F274-CA48-45E2-A3FC-60409F02F2CB Q38552201-50AF9A47-7BDD-4AAE-AAC1-0D7DDFDA2C1D Q38620686-87ED5256-3078-4FB4-A6B0-C4B208518441 Q39363836-2C30E363-9869-4430-8364-E15A4864F801 Q41221983-0DA2309E-DBA8-411F-A38A-D38B72C3A8C4 Q41551818-A42E27B1-4B1E-40E1-ADD1-1EF05D711907 Q42620850-B3176A88-E220-48A7-A514-8574098987A7 Q43585852-AAD87B2F-2EEE-4EFC-8747-A0CC24BC5A62 Q46135644-09B50525-9311-4C0C-B3E9-032F0E310FA6 Q46484331-97923D91-95DC-43F2-86FD-94B6E61C407F Q47877699-80F64A9A-B883-493B-B4CF-F03DE4E5D715 Q50724315-EE52F305-A0E8-4291-A2B1-8EB8D67D6FC6 Q52720499-C5110CC7-70BE-41F5-96A5-7C86D6A415BF Q54390436-4CDEFF02-F22A-4AD2-A212-49346EEFCABD

P2860

B cell depletion therapy exacerbates murine primary biliary cirrhosis

http://www.wikidata.org/entity/Q34678839

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

B cell depletion therapy exacerbates murine primary biliary cirrhosis

@ast

B cell depletion therapy exacerbates murine primary biliary cirrhosis

@en

B cell depletion therapy exacerbates murine primary biliary cirrhosis

@nl

type

label

B cell depletion therapy exacerbates murine primary biliary cirrhosis

@ast

B cell depletion therapy exacerbates murine primary biliary cirrhosis

@en

B cell depletion therapy exacerbates murine primary biliary cirrhosis

@nl

prefLabel

B cell depletion therapy exacerbates murine primary biliary cirrhosis

@ast

B cell depletion therapy exacerbates murine primary biliary cirrhosis

@en

B cell depletion therapy exacerbates murine primary biliary cirrhosis

@nl

P1433

Q34678839-9A5C20A8-B32E-42FD-8F97-7B14D284718B

P1476

Q34678839-9DFF8015-B181-4243-B354-1CDFF93A00ED

P2093

Q34678839-0318059C-15BC-405C-A40A-F93D3603A9E7

Q34678839-076D93BA-5835-4A2D-88B3-ABDA805B9561

Q34678839-2233DE99-1C0E-46CB-B519-FCDA99124340

Q34678839-23EAF086-B68A-4262-B171-1FB49AF89ECE

Q34678839-31546215-0478-4639-ADAA-A5CB6A5C5A4E

Q34678839-8F2802E2-9D41-4184-AD55-D81AFDE30ED7

Q34678839-9A086DD0-67CF-4E34-BFA3-B1EA26450FF6

Q34678839-A0F29B11-7EA8-418B-9201-15C7BB1166AB

Q34678839-E1E21021-E631-44F4-8E34-99F3B9D58504

Q34678839-F21D6CC3-2CEA-43B8-B4D9-B274664C5941

P2860

Q34678839-120EB200-685F-4AC0-BAC3-C696D5EE2C02

Q34678839-13CD0149-901A-4EF1-90D8-F5F635F09209

Q34678839-1685B2A3-067B-4C09-B399-CF4D63E7FB06

Q34678839-18549F8A-8744-45F8-A958-8B11538E72F0

Q34678839-1B16CE27-77BE-4D15-BB42-C9B54AD7AA5E

Q34678839-2B86FA42-1862-43E3-9DD2-B28EB4BCB096

Q34678839-33D3847B-3DE2-49B3-8733-0B5C4F80E327

Q34678839-3ABCEE36-72D4-4317-B55D-97C216DA31C8

Q34678839-3B96C1DE-F076-4CE6-BCAB-B45480E549C4

Q34678839-410470BA-B702-4E9E-8F0E-FF70F85F74C2

P304

Q34678839-517E6477-6E43-46D4-8EA7-08865D8B0B19

P31

Q34678839-012A2B0B-A9D1-47B3-8BCC-F8706F42B783

P356

Q34678839-450AC380-9567-4F3C-B1CE-5D7DD58209E3

P407

Q34678839-860A525A-B293-4923-9D50-4920CB26CC38

P433

Q34678839-73DBBA6C-E0CC-4E7A-99F1-07B2911F87DA

P478

Q34678839-F7C07995-5DCB-4B95-931C-DC513C1A5332

P50

Q34678839-431AFEB4-A4CE-4E31-A049-4CF9E38DC6BD

Q34678839-7A92745D-D1EB-4A66-9F50-FC3CA0986EEA

Q34678839-B3BEBC7A-DC0E-4CC0-BB2F-54ABCD181F2E

P577

Q34678839-83383270-B3F9-49E6-B998-122FC1C4E7D4

P5875

Q34678839-BA647DD7-6376-4F4F-950C-083D880D24D3

P698

Q34678839-6DFFEAD6-DAC7-405E-A410-0AEC6520C050

P932

Q34678839-F8BB4272-7EC0-46C9-B8A1-C895412898DD

P356

P1433

P1476

B cell depletion therapy exacerbates murine primary biliary cirrhosis

@en

P2093

Amy Dhirapong

http://www.w3.org/2001/XMLSchema#string

Ana Lleo

http://www.w3.org/2001/XMLSchema#string

Fu-Tong Liu

http://www.w3.org/2001/XMLSchema#string

Guo-Xiang Yang

http://www.w3.org/2001/XMLSchema#string

John C Cambier

http://www.w3.org/2001/XMLSchema#string

Keith Lindor

http://www.w3.org/2001/XMLSchema#string

Koichi Tsuneyama

http://www.w3.org/2001/XMLSchema#string

Marilyn Kehry

http://www.w3.org/2001/XMLSchema#string

Robert Dunn

http://www.w3.org/2001/XMLSchema#string

Thomas A Packard

http://www.w3.org/2001/XMLSchema#string

P2860

Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future

Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase.

B cell depletion with anti-CD79 mAbs ameliorates autoimmune disease in MRL/lpr mice.

B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice

B cells regulate autoimmunity by provision of IL-10.

Prevention of arthritis by interleukin 10-producing B cells.

Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid.

Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.

Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.

B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis

P304

527-535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.24044

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

M. Eric Gershwin

Aftab A. Ansari

P577

2010-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49792503

http://www.w3.org/2001/XMLSchema#string

P698

21274873

http://www.w3.org/2001/XMLSchema#string

P932

3058242

http://www.w3.org/2001/XMLSchema#string